339 related articles for article (PubMed ID: 16815858)
21. Everolimus in clinical practice--renal transplantation.
Pascual J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
[TBL] [Abstract][Full Text] [Related]
22. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.
Kovarik JM; Eisen H; Dorent R; Mancini D; Vigano M; Rouilly M; Hsu CH; Rordorf C
J Heart Lung Transplant; 2003 Oct; 22(10):1117-25. PubMed ID: 14550821
[TBL] [Abstract][Full Text] [Related]
23. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.
Snell GI; Valentine VG; Vitulo P; Glanville AR; McGiffin DC; Loyd JE; Roman A; Aris R; Sole A; Hmissi A; Pirron U;
Am J Transplant; 2006 Jan; 6(1):169-77. PubMed ID: 16433771
[TBL] [Abstract][Full Text] [Related]
24. Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
Zuckermann A; Arizon JM; Dong G; Eisen HJ; Kobashigawa J; Lehmkuhl H; Ross H; Pelligrini C; Wang SS; Barten MJ
Transplantation; 2011 Sep; 92(5):594-600. PubMed ID: 21862955
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
[TBL] [Abstract][Full Text] [Related]
26. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
Shihab FS; Cibrik D; Chan L; Kim YS; Carmellini M; Walker R; Zibari G; Pattison J; Cornu-Artis C; Wang Z; Tedesco-Silva H
Clin Transplant; 2013; 27(2):217-26. PubMed ID: 23230975
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S; Andreassen AK; Andersson B; Gustafsson F; Eiskjaer H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Sigurdardottir V; Dellgren G; Erikstad I; Solberg OG; Ueland T; Aukrust P; Gullestad L;
Am J Transplant; 2015 Jul; 15(7):1967-75. PubMed ID: 25783974
[TBL] [Abstract][Full Text] [Related]
28. Everolimus.
Chapman TM; Perry CM
Drugs; 2004; 64(8):861-72; discussion 873-4. PubMed ID: 15059040
[TBL] [Abstract][Full Text] [Related]
29. Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil--one single-center experience.
Chou NK; Jan CF; Chi NH; Lee CM; Wu IH; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Chu SH; Wang SS
Transplant Proc; 2012 May; 44(4):897-9. PubMed ID: 22564578
[TBL] [Abstract][Full Text] [Related]
30. Influence of everolimus on cyclosporine Neoral pharmacokinetics in Chinese de novo cardiac transplant recipients.
Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
Transplant Proc; 2006 Sep; 38(7):2032-4. PubMed ID: 16979990
[TBL] [Abstract][Full Text] [Related]
31. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
Kovarik JM; Snell GI; Valentine V; Aris R; Chan CK; Schmidli H; Pirron U
J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
[TBL] [Abstract][Full Text] [Related]
32. RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection.
Kahan BD; Kaplan B; Lorber MI; Winkler M; Cambon N; Boger RS
Transplantation; 2001 May; 71(10):1400-6. PubMed ID: 11391226
[TBL] [Abstract][Full Text] [Related]
33. Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
Arora S; Andreassen AK; Karason K; Gustafsson F; Eiskjær H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Dellgren G; Ueland T; Aukrust P; Gullestad L;
Circ Heart Fail; 2018 Sep; 11(9):e004050. PubMed ID: 30354362
[TBL] [Abstract][Full Text] [Related]
34. Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.
Gonzalez F; Espinoza M; Herrera P; Rocca X; Reynolds E; Lorca E; Roessler E; Hidalgo J; Espinoza O
Transplant Proc; 2010; 42(1):270-2. PubMed ID: 20172327
[TBL] [Abstract][Full Text] [Related]
35. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Levy G; Schmidli H; Punch J; Tuttle-Newhall E; Mayer D; Neuhaus P; Samuel D; Nashan B; Klempnauer J; Langnas A; Calmus Y; Rogiers X; Abecassis M; Freeman R; Sloof M; Roberts J; Fischer L
Liver Transpl; 2006 Nov; 12(11):1640-8. PubMed ID: 16598777
[TBL] [Abstract][Full Text] [Related]
36. Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?
Farsetti S; Zanazzi M; Caroti L; Rosso G; Larti A; Marcucci R; Fedi S; Rogolino A; Cellai AP; Abbate R; Bertoni E; Salvadori M
Transplant Proc; 2010 May; 42(4):1381-2. PubMed ID: 20534308
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Kahan BD
Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
[TBL] [Abstract][Full Text] [Related]
38. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
39. Everolimus in cardiac-transplant recipients.
Banas B; Böger C; Krämer B
N Engl J Med; 2003 Dec; 349(23):2271-2; author reply 2271-2. PubMed ID: 14657441
[No Abstract] [Full Text] [Related]
40. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
Tsai MK; Chueh SC; Hu RH; Lee PH
J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
